Search

Your search keyword '"Kundu, Madan G."' showing total 17 results
Start Over Author "Kundu, Madan G." Publication Year Range Last 3 years
17 results on '"Kundu, Madan G."'

3. Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non–Squamous Non–Small Cell Lung Cancer

Author

Govindan, Ramaswamy, Lind, Mike, Insa, Amelia, Khan, Saad A., Uskov, Dmitry, Tafreshi, Ali, Guclu, Salih, Bar, Jair, Kato, Terufumi, Lee, Ki Hyeong, Nakagawa, Kazuhiko, Hansen, Olfred, Biesma, Bonne, Kundu, Madan G., Dunbar, Martin, He, Lei, Ansell, Peter, Sehgal, Vasudha, Huang, Xin, Glasgow, Jaimee, and Bach, Bruce A.

Published
2022
Full Text
View/download PDF

4. Supplementary Tables 1-4 from A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor

Author

George, Suzanne, primary, Heinrich, Michael C., primary, Somaiah, Neeta, primary, Oppelt, Peter, primary, McLeod, Robert, primary, Nishioka, Satoshi, primary, Kundu, Madan G., primary, Qian, Xiaozhong, primary, Kumar, Prasanna, primary, Laadem, Abderrahmane, primary, Lau, Yvonne, primary, Tran, Brittany P., primary, Fallon, Maura, primary, Dosunmu, Ololade, primary, Shi, Julia, primary, and Naito, Yoichi, primary

Published
2023
Full Text
View/download PDF

5. Data from A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor

Author

George, Suzanne, primary, Heinrich, Michael C., primary, Somaiah, Neeta, primary, Oppelt, Peter, primary, McLeod, Robert, primary, Nishioka, Satoshi, primary, Kundu, Madan G., primary, Qian, Xiaozhong, primary, Kumar, Prasanna, primary, Laadem, Abderrahmane, primary, Lau, Yvonne, primary, Tran, Brittany P., primary, Fallon, Maura, primary, Dosunmu, Ololade, primary, Shi, Julia, primary, and Naito, Yoichi, primary

Published
2023
Full Text
View/download PDF

6. Supplementary Appendix 1 from A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor

Author

George, Suzanne, primary, Heinrich, Michael C., primary, Somaiah, Neeta, primary, Oppelt, Peter, primary, McLeod, Robert, primary, Nishioka, Satoshi, primary, Kundu, Madan G., primary, Qian, Xiaozhong, primary, Kumar, Prasanna, primary, Laadem, Abderrahmane, primary, Lau, Yvonne, primary, Tran, Brittany P., primary, Fallon, Maura, primary, Dosunmu, Ololade, primary, Shi, Julia, primary, and Naito, Yoichi, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Figure S1 from A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor

Author

George, Suzanne, primary, Heinrich, Michael C., primary, Somaiah, Neeta, primary, Oppelt, Peter, primary, McLeod, Robert, primary, Nishioka, Satoshi, primary, Kundu, Madan G., primary, Qian, Xiaozhong, primary, Kumar, Prasanna, primary, Laadem, Abderrahmane, primary, Lau, Yvonne, primary, Tran, Brittany P., primary, Fallon, Maura, primary, Dosunmu, Ololade, primary, Shi, Julia, primary, and Naito, Yoichi, primary

Published
2023
Full Text
View/download PDF

8. A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor

Author

George, Suzanne, primary, Heinrich, Michael C., additional, Somaiah, Neeta, additional, Oppelt, Peter, additional, McLeod, Robert, additional, Nishioka, Satoshi, additional, Kundu, Madan G., additional, Qian, Xiaozhong, additional, Kumar, Prasanna, additional, Laadem, Abderrahmane, additional, Lau, Yvonne, additional, Tran, Brittany P., additional, Fallon, Maura, additional, Dosunmu, Ololade, additional, Shi, Julia, additional, and Naito, Yoichi, additional

Published
2023
Full Text
View/download PDF

10. Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial

Author

MS Medische Oncologie, Cancer, Lassman, Andrew B, Pugh, Stephanie L, Wang, Tony J C, Aldape, Kenneth, Gan, Hui K, Preusser, Matthias, Vogelbaum, Michael A, Sulman, Erik P, Won, Minhee, Zhang, Peixin, Moazami, Golnaz, Macsai, Marian S, Gilbert, Mark R, Bain, Earle E, Blot, Vincent, Ansell, Peter J, Samanta, Suvajit, Kundu, Madan G, Armstrong, Terri S, Wefel, Jeffrey S, Seidel, Clemens, de Vos, Filip Y, Hsu, Sigmund, Cardona, Andrés F, Lombardi, Giuseppe, Bentsion, Dmitry, Peterson, Richard A, Gedye, Craig, Bourg, Véronique, Wick, Antje, Curran, Walter J, Mehta, Minesh P, MS Medische Oncologie, Cancer, Lassman, Andrew B, Pugh, Stephanie L, Wang, Tony J C, Aldape, Kenneth, Gan, Hui K, Preusser, Matthias, Vogelbaum, Michael A, Sulman, Erik P, Won, Minhee, Zhang, Peixin, Moazami, Golnaz, Macsai, Marian S, Gilbert, Mark R, Bain, Earle E, Blot, Vincent, Ansell, Peter J, Samanta, Suvajit, Kundu, Madan G, Armstrong, Terri S, Wefel, Jeffrey S, Seidel, Clemens, de Vos, Filip Y, Hsu, Sigmund, Cardona, Andrés F, Lombardi, Giuseppe, Bentsion, Dmitry, Peterson, Richard A, Gedye, Craig, Bourg, Véronique, Wick, Antje, Curran, Walter J, and Mehta, Minesh P

Published
2023

12. Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial

Author

Lassman, Andrew B, primary, Pugh, Stephanie L, additional, Wang, Tony J C, additional, Aldape, Kenneth, additional, Gan, Hui K, additional, Preusser, Matthias, additional, Vogelbaum, Michael A, additional, Sulman, Erik P, additional, Won, Minhee, additional, Zhang, Peixin, additional, Moazami, Golnaz, additional, Macsai, Marian S, additional, Gilbert, Mark R, additional, Bain, Earle E, additional, Blot, Vincent, additional, Ansell, Peter J, additional, Samanta, Suvajit, additional, Kundu, Madan G, additional, Armstrong, Terri S, additional, Wefel, Jeffrey S, additional, Seidel, Clemens, additional, de Vos, Filip Y, additional, Hsu, Sigmund, additional, Cardona, Andrés F, additional, Lombardi, Giuseppe, additional, Bentsion, Dmitry, additional, Peterson, Richard A, additional, Gedye, Craig, additional, Bourg, Véronique, additional, Wick, Antje, additional, Curran, Walter J, additional, and Mehta, Minesh P, additional

Published
2022
Full Text
View/download PDF

13. Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.

Author

Lassman, Andrew B, Pugh, Stephanie L, Wang, Tony J C, Aldape, Kenneth, Gan, Hui K, Preusser, Matthias, Vogelbaum, Michael A, Sulman, Erik P, Won, Minhee, Zhang, Peixin, Moazami, Golnaz, Macsai, Marian S, Gilbert, Mark R, Bain, Earle E, Blot, Vincent, Ansell, Peter J, Samanta, Suvajit, Kundu, Madan G, Armstrong, Terri S, and Wefel, Jeffrey S

Published
2023
Full Text
View/download PDF

14. Final Results of a Phase 1b Study of BET Inhibitor PLX2853 in Patients with Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Author

Mims, Alice S., primary, Solh, Melhem, additional, Saultz, Jennifer N., additional, Borate, Uma, additional, Pemmaraju, Naveen, additional, Borthakur, Gautam, additional, Roboz, Gail J., additional, Powell, Ben, additional, Matusow, Bernice, additional, Halladay, Jason, additional, Vali, Shireen, additional, Hope, Chelsea L., additional, Kundu, Madan G., additional, Hsu, Ching, additional, Watkins, Paul, additional, Zhang, Chao, additional, Walling, Jackie M., additional, Tsiatis, Athanasios C., additional, and DeZern, Amy E., additional

Published
2021
Full Text
View/download PDF

15. Methods and Applications of Sample Size Calculation and Recalculation in Clinical Trials: by Meinhard Kieser, (Springer Series in Pharmaceutical Statistics, 2020.).

Author

Kundu, Madan G.

Subjects
*SAMPLE size (Statistics), *CLINICAL trials, *FISHER exact test, *LOG-rank test
Abstract

One of the key aspects of designing a clinical trial is sample size estimation. The quantity ' I nc i ' is also a function of sample size, and therefore, the required sample size can be obtained by solving this equation for the sample size. The introductory Chapter 1 provides an excellent description of the basic principles for the sample size calculation and the factors that influence sample size. [Extracted from the article]

Published
2022
Full Text
View/download PDF

17. Closed-Form Approximation of Correlation Matrix Among Fleming Harrington Test Statistics in MaxCombo Test: Comments on "Robust Design and Analysis of Clinical Trials With Nonproportional Hazards: A Straw Man Guidance From a Cross-Pharma Working Group".

Author

Kundu, Madan G.

Subjects
*EXPERIMENTAL design, *STATISTICAL correlation, *STATISTICS, *MATRICES (Mathematics), *HAZARDS
Abstract

Roychoudhury et al. recently proposed a robust MaxCombo test that considers the maximum of four "correlated" test statistics from FH(0, 0), FH(0, 1), FH(1, 0), and FH(1, 1) tests. Their formulation needs estimation of correlations of these test statistics, and they obtained the correlation matrix via simulation. I have described a closed-form solution to obtain this correlation matrix under the "no censoring" assumption that depends only on sample size and planned number of events. This approach has been extended for group-sequential design as well. Our correlation matrix is very close to the one obtained by Roychoudhury et al. via simulation. In addition, we have also made remarks on the work of Roychoudhury et al. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results